Lapatinib-Capecitabine Versus Capecitabine Alone as Radiosensitizers in Ras Wild-Type Resectable Rectal Cancer, an Adaptive Randomized Phase Ii Trial (Larrc Trial): Study Protocol for a Randomized Controlled Trial
AuthID
P-00K-X85
P-00K-X85